Local Institution - 0002 — Nashville, Tennessee

Local Institution - 0002 is a clinical research site located in Nashville, Tennessee, United States 37203-1624.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 0002 has participated in 3 clinical trials.

Therapeutic areas: Renal Cell Carcinoma, Advanced Solid Cancers, Advanced or Metastatic Solid Tumors.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0002?

Local Institution - 0002 has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0002 conducted?

Local Institution - 0002 has 3 clinical trials on record. Their work covers Renal Cell Carcinoma, Advanced Solid Cancers, Advanced or Metastatic Solid Tumors.

Is Local Institution - 0002 accredited by Crixeo Health?

Local Institution - 0002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.